ResearcherFirst Affiliated Hospital of Guangzhou University of Chinese MedicineNo recent work listed
Xin Chun Shang
Matched on ORCID iD 0000-0001-6949-5046; OpenAlex author ID A5066059509. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 5
2020: 2 papers · 2021: 1 paper
Papers 3
- A Novel miRNA-mRNA Axis Involves in Regulating Transcriptional Disorders in Pancreatic Adenocarcinoma. Co-author DOI 10.2147/cmar.s316935↗
- Identification of hub genes correlated with the pathogenesis and prognosis in Pancreatic adenocarcinoma on bioinformatics methods. First author DOI 10.21037/tcr-19-2873↗
- Identification of potential crucial genes associated with the pathogenesis and prognosis of pancreatic adenocarcinoma. First author DOI 10.3892/ol.2020.11921↗
Closest collaborators
The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Laner Shi · 3 shared papers, 2020–2021 · strength 0.45
- Paper A Novel miRNA-mRNA Axis Involves in Regulating Transcriptional Disorders in Pancreatic Adenocarcinoma. DOI 10.2147/cmar.s316935↗
- Paper Identification of potential crucial genes associated with the pathogenesis and prognosis of pancreatic adenocarcinoma. DOI 10.3892/ol.2020.11921↗
- Paper Identification of hub genes correlated with the pathogenesis and prognosis in Pancreatic adenocarcinoma on bioinformati… DOI 10.21037/tcr-19-2873↗
- Zhang-Zhi Zhu · 2 shared papers, 2020–2021 · strength 0.32
- Kechao Nie · 2 shared papers, 2020 · strength 0.26
- Paper Identification of potential crucial genes associated with the pathogenesis and prognosis of pancreatic adenocarcinoma. DOI 10.3892/ol.2020.11921↗
- Paper Identification of hub genes correlated with the pathogenesis and prognosis in Pancreatic adenocarcinoma on bioinformati… DOI 10.21037/tcr-19-2873↗
- Zhangzhi Zhu · 1 shared paper, 2020 · strength 0.13
- Miao Wang · 1 shared paper, 2020 · strength 0.13
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.